# BTB Therapeutics, Inc. — Form D

BTB Therapeutics, Inc. of ESCONDIDO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2025-02-05. The offering totals $3.3M, of which $3.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2025-02-05
- Form: D
- Accession: 0002055053-25-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.3M
- Amount sold: $3.3M
- Remaining: $82
- Investors: 10
- Date of first sale: 2025-01-30
- Security types: equity, debt
- Revenue range: Decline to Disclose
- SEC file number: 021-537472

## Issuer

- Name: BTB Therapeutics, Inc.
- CIK: 0002055053
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 26281 WYNDEMERE COURT, ESCONDIDO, CA, 92026
- Phone: (858) 945-3733

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| David Snyder | Director | Philadelphia, PA |
| Masatoshi Hagiwara | Director | Escondido, CA |
| Nobuhiro Yagi | Director | Escondido, CA |
| Takashi Kiyoizumi | Director | Escondido, CA |
| Takashi Kiyoizumi | Executive Officer | Escondido, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2025-12-01](https://search.stillhousedata.com/formd/0002055053-25-000003) | D | $7.4M | $3.4M |

## More

- [CIK 2055053 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2055053&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002055053-25-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.